Description
GelXA FIBRIN builds on the versatile GelXA platform, incorporating fibrinogen to support the study of wound‑healing environments. After enzymatic crosslinking with thrombin, the fibrinogen forms complex and stable fibrin networks that mimic physiological repair processes. GelXA FIBRIN offers dual crosslinking through photocuring and ionic treatment with the thrombin‑containing Crosslinking Agent, enabling rapid stabilization and the formation of durable 3D constructs.
Specifications
| Appearance | Semi-translucent gel |
| Sterility | Sterile |
| pH | 6.5-7.4 |
| Viscosity | 70–330 Pa·s at 1 s-1 |
| Degree of methacrylation | 45-65% |
| Shelf life | Minimum 1.5 months |
| Storage conditions | 2-10°C, do not freeze |
| Kit components |
GelXA FIBRIN 3 x 3 mL cartridges
CaCl2 Crosslinking Agent, 45 mL
Thrombin
|
| Use | For research use only. Not for human use. Light-sensitive product. Should be protect from light during storage and handling. |
Publications
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation
Ronzoni, F. L., Aliberti, F., Scocozza, F., Benedetti, L., Auricchio, F., Sampaolesi, M., Cusella, G., Redwan, I. N., Ceccarelli, G., & Conti, M. Journal of Tissue Engineering and Regenerative Medicine, 16(5), 484–495. (2022).
https://doi.org/10.1002/term.3293
